Back
Editas Medicine Vs. Simulations Plus Industry Stock Comparison
Sell
21
EDIT
Editas Medicine
Last Price:
$1.29
Seasonality Move:
2.34%
Sell
47
SLP
Simulations Plus
Last Price:
$32.67
Seasonality Move:
0.1%
Sell
21
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.28. The Score for EDIT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
-
The current Simulations Plus [SLP] share price is $32.69. The Score for SLP is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SLP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight buying pressure.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $32.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLP is experiencing slight buying pressure.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 49.43 | Sell |
| Chaikin Money Flow: | 54529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.12 - 1.38) | Buy |
| Bollinger Bands (100): | (1.12 - 1.94) | Sell |
SLP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.22 | Buy |
| Relative Strength Index (14 RSI): | 65.98 | Buy |
| Chaikin Money Flow: | 166950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.31 - 29.81) | Buy |
| Bollinger Bands (100): | (26.39 - 33.49) | Buy |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.22 | Buy |
| 20-day SMA: | 1.21 | Buy |
| 50-day SMA: | 1.45 | Sell |
| 200-day SMA: | 2.74 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 1.07 | Buy |
| 50-day EMA: | 0.69 | Buy |
| 200-day EMA: | 0.23 | Buy |
SLP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.01 | Buy |
| 20-day SMA: | 26.8 | Buy |
| 50-day SMA: | 29.33 | Buy |
| 200-day SMA: | 32.5 | Buy |
| 8-day EMA: | 30.6 | Buy |
| 20-day EMA: | 28.45 | Buy |
| 50-day EMA: | 28.64 | Buy |
| 200-day EMA: | 32.58 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.11 per share, an increase this year of $0.56 per share, and an increase next year of $0.14 per share.
Editas Medicine Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Simulations Plus Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||